---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/38950083.md"
description: "The biggest cost of drugs is drug R&D. Traditional drug R&D is like a manual workshop. Eli Lilly's AI factory is the steam engine of drug R&D, with efficiency and cost that crush other pharmaceutical companies. This is also why Eli Lilly's tirzepatide is more effective than NVO's."
datetime: "2026-02-27T15:11:52.000Z"
locales:
  - [en](https://longbridge.com/en/topics/38950083.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/38950083.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/38950083.md)
author: "[第一公民的交易员](https://longbridge.com/en/profiles/11714872.md)"
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/topics/38950083.md) | [繁體中文](https://longbridge.com/zh-HK/topics/38950083.md)


# The biggest cost of drugs is drug R&D. Traditi…


### Related Stocks

- [Novo Nordisk A/S (NVO.US)](https://longbridge.com/en/quote/NVO.US.md)
- [Eli Lilly and Company (LLY.US)](https://longbridge.com/en/quote/LLY.US.md)

## Comments (1)

- **青禾投研 · 2026-03-02T00:35:18.000Z**: This doesn't have a very high barrier to entry. For major players in vertical sectors to implement AI, it's not that difficult.